In vivo cell kinetics in breast carcinogenesis

Breast Cancer Research

Volumn 3, Issue 4, 2001, Pages 276-283

  Bai, Maria ^a   Agnantis, Niki J ^a   Kamina, Sevasti ^a   Demou, Asimina ^a   Zagorianakou, Panayiota ^a   Katsaraki, Aphroditi ^b   Kanavaros, Panayiotis ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Apoptosis; Breast carcinoma; Hyperplasia; Proliferation

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST LESION; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CELL GROWTH; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MODEL; EPITHELIUM CELL; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; NICK END LABELING; TUMOR GROWTH; TURNOVER TIME;

ADULT; AGED; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERPLASIA; MIDDLE AGED; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS;

EID: 0034942955     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr306     Document Type: Article

References (45)

1. The cell cycle and cell death
2. Molecular controls of apoptosis: Differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulators
3. Molecular regulation of apoptosis: Genetic controls on cell death
4. A matter of life and cell death
5. Apoptosis in the pathogenesis and treatment of disease
6. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
7. Early phases in the development of breast cancer
8. Borderline mammary lesions
9. Biopathological aspects of breast cancer
10. Biological and molecular bases of mammary carcinogenesis
11. Balance of cell proliferation and apoptosis in breast carcinogenesis
12. The clinical behavior or breast cancer is probably determined at the preinvasive stage (ductal carcinoma in situ)
13. Different proliferative patterns characterize different preinvasive breast lesions
14. Immunohistochemical localization of Bcl-2 and Bax proteins in in-situ and invasive duct breast carcinomas
15. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast
16. Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating ductal carcinoma of human breast cancer that correlates with altered p53 expression: Detected by nick and labeling (TUNEL)
17. Combined histological and cytological criteria for the diagnosis of mammary atypical ductal hyperplasia
18. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
19. Ductal carcinoma in situ: A proposal for a new classification
20. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67
21. Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67
22. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions
23. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas
24. Apoptotic activity is increased in parallel with metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium
25. Apoptosis, proliferation and angiogenesis in oral tissues. Possible relevance to tumour progression
26. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling
27. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note
28. Extensive apoptosis in ductal carcinoma in situ of the breast
29. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast
30. Prognostic classification of breast ductal carcinoma in situ
31. Mammographically detected duct carcinoma in-situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
32. Atypical ductal hyperplasia of the breast: Clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p
33. Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction
34. Apoptosis in breast cancer as related to histopathological characteristics and prognosis
35. Bcl-2 and apoptosis in lymph node positive breast carcinoma
36. Spontaneous programmed cell death in infiltrating duct carcinoma: Association with p53, bcl-2, hormone receptors and tumor proliferation
37. Correlations between apoptotic and proliferative indices in malignant non-Hodgkins lymphomas
38. Bcl-2 expression, p53 accumulation and apoptosis in ovarian carcinomas
39. Apoptosis in human hepatocellular carcinomas and in liver cell dysplasia is correlated with p53 protein immunoreactivity
40. Spontaneous apoptosis in laryngeal squamous cell carcinomas is independent of bcl-2 and bax expression
41. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells
42. Activation of cyclin A dependent protein kinases during apoptosis
43. Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL-60 cells undergoing apoptosis induced by DNA-damage
44. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections in an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein mitotic index, and other clinicopathologic variables
45. The association between cell proliferation and apoptosis: Studies using the cell cycle-associated protein Ki-67 and DNA polymerase alpha